Optic Atrophy

Gene: ATAD3A

Green List (high evidence)

ATAD3A (ATPase family, AAA domain containing 3A)
EnsemblGeneIds (GRCh38): ENSG00000197785
EnsemblGeneIds (GRCh37): ENSG00000197785
OMIM: 612316, Gene2Phenotype
ATAD3A is in 9 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Comment when marking as ready: Optic atrophy reported in individuals with the recurrent de novo missense p.Arg528Trp only at this stage.
Created: 9 Apr 2020, 7:04 a.m. | Last Modified: 9 Apr 2020, 7:04 a.m.
Panel Version: 0.49

Elena Savva (Victorian Clinical Genetics Services)

Green List (high evidence)

PMID: 27640307 - Recurring de novo missense causing GDD, neuropathy, cardiomyopathy and optic atrophy
Optic atrophy reported in 3/5 families with de novo recurring missense
But NONE of the families with biallelic variants (0/2) - hom missense and biallelic CNV deletion
Fruit fly model -> expression causes loss of mitochondria, a phenotype midly replicated by analysis of a single patient's cells. Dom neg effect suggested

PMID: 28652416 - discusses ^ findings, nothing new
Created: 9 Apr 2020, 1:20 a.m. | Last Modified: 9 Apr 2020, 1:20 a.m.
Panel Version: 0.11

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Harel-Yoon syndrome

Publications

Mode of pathogenicity
Other

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
Phenotypes
  • Harel-Yoon syndrome, MIM#617183
OMIM
612316
Clinvar variants
Variants in ATAD3A
Penetrance
None
Publications
Mode of Pathogenicity
Other
Panels with this gene

History Filter Activity

9 Apr 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: atad3a has been classified as Green List (High Evidence).

9 Apr 2020, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: ATAD3A were changed from to Harel-Yoon syndrome, MIM#617183

9 Apr 2020, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: ATAD3A were set to 27640307; 28652416

9 Apr 2020, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: ATAD3A were set to

9 Apr 2020, Gel status: 3

Set mode of pathogenicity

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of pathogenicity for gene: ATAD3A was changed from to Other

9 Apr 2020, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: ATAD3A was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: ATAD3A was added gene: ATAD3A was added to Optic Atrophy_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: ATAD3A was set to Unknown